APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Next-Generation Sequencing (NGS) Services

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

Selected research

Market Outlook & Growth Opportunities

Global Next-Generation Sequencing (NGS) Services Market Outlook and Growth Opportunities 2026

Report ID 174016790428 December 2025190 pages

Choose your research edition.

Industry ResearchNext-Generation Sequencing (NGS) Services Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Next-Generation Sequencing (NGS) Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Next-Generation Sequencing (NGS) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next-Generation Sequencing (NGS) Services Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Next-Generation Sequencing (NGS) Services Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.

Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.

Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.

This report provides an overview of the global Next-Generation Sequencing (NGS) Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Next-Generation Sequencing (NGS) Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Next-Generation Sequencing (NGS) Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Next-Generation Sequencing (NGS) Services market.

Next-Generation Sequencing (NGS) Services Segment by Company

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

Next-Generation Sequencing (NGS) Services Segment by Type

Targeted Sequencing

Whole Exome Sequencing

Whole Genome Sequencing

Next-Generation Sequencing (NGS) Services Segment by Application

Hospitals and Clinics

Biopharma Companies

Academic & Research Organizations

Others

Next-Generation Sequencing (NGS) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Next-Generation Sequencing (NGS) Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Next-Generation Sequencing (NGS) Services key companies, revenue, market share, and recent developments.

3. To split the Next-Generation Sequencing (NGS) Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Next-Generation Sequencing (NGS) Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Next-Generation Sequencing (NGS) Services significant trends, drivers, influence factors in global and regions.

6. To analyze Next-Generation Sequencing (NGS) Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next-Generation Sequencing (NGS) Services industry.

Chapter 3: Detailed analysis of Next-Generation Sequencing (NGS) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Next-Generation Sequencing (NGS) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Next-Generation Sequencing (NGS) Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Next-Generation Sequencing (NGS) Services Industry Trends Table 2. Next-Generation Sequencing (NGS) Services Industry Drivers Table 3. Next-Generation Sequencing (NGS) Services Industry Opportunities and Challenges Table 4. Next-Generation Sequencing (NGS) Services Industry Restraints Table 5. Global Next-Generation Sequencing (NGS) Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Next-Generation Sequencing (NGS) Services Revenue Share by Company (2021-2026) Table 7. Global Next-Generation Sequencing (NGS) Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Next-Generation Sequencing (NGS) Services Key Company Manufacturing Base & Headquarters Table 9. Global Next-Generation Sequencing (NGS) Services Company, Product Type & Application Table 10. Global Next-Generation Sequencing (NGS) Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Next-Generation Sequencing (NGS) Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Targeted Sequencing Table 15. Significant Companies of Whole Exome Sequencing Table 16. Significant Companies of Whole Genome Sequencing Table 17. Global Next-Generation Sequencing (NGS) Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Type (2021-2026) Table 21. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals and Clinics Table 23. Significant Companies of Biopharma Companies Table 24. Significant Companies of Academic & Research Organizations Table 25. Significant Companies of Others Table 26. Global Next-Generation Sequencing (NGS) Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Application (2021-2026) Table 30. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Application (2027-2032) Table 31. Global Next-Generation Sequencing (NGS) Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Region (2021-2026) Table 34. Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Region (2027-2032) Table 36. Global Next-Generation Sequencing (NGS) Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Next-Generation Sequencing (NGS) Services Sales Value Market Share by Country (2021-2026) Table 39. Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Next-Generation Sequencing (NGS) Services Sales Value Market Share by Country (2027-2032) Table 41. Eurofins Scientific Company Information Table 42. Eurofins Scientific Business Overview Table 43. Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Eurofins Scientific Next-Generation Sequencing (NGS) Services Product Portfolio Table 45. Eurofins Scientific Recent Development Table 46. Natera Company Information Table 47. Natera Business Overview Table 48. Natera Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Natera Next-Generation Sequencing (NGS) Services Product Portfolio Table 50. Natera Recent Development Table 51. BGI Company Information Table 52. BGI Business Overview Table 53. BGI Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. BGI Next-Generation Sequencing (NGS) Services Product Portfolio Table 55. BGI Recent Development Table 56. Illumina Company Information Table 57. Illumina Business Overview Table 58. Illumina Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Illumina Next-Generation Sequencing (NGS) Services Product Portfolio Table 60. Illumina Recent Development Table 61. Roche Company Information Table 62. Roche Business Overview Table 63. Roche Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Roche Next-Generation Sequencing (NGS) Services Product Portfolio Table 65. Roche Recent Development Table 66. LabCorp Company Information Table 67. LabCorp Business Overview Table 68. LabCorp Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. LabCorp Next-Generation Sequencing (NGS) Services Product Portfolio Table 70. LabCorp Recent Development Table 71. Berry Genomics Company Information Table 72. Berry Genomics Business Overview Table 73. Berry Genomics Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Berry Genomics Next-Generation Sequencing (NGS) Services Product Portfolio Table 75. Berry Genomics Recent Development Table 76. Brooks Life Sciences Company Information Table 77. Brooks Life Sciences Business Overview Table 78. Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product Portfolio Table 80. Brooks Life Sciences Recent Development Table 81. Macrogen Company Information Table 82. Macrogen Business Overview Table 83. Macrogen Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Macrogen Next-Generation Sequencing (NGS) Services Product Portfolio Table 85. Macrogen Recent Development Table 86. Personalis Company Information Table 87. Personalis Business Overview Table 88. Personalis Next-Generation Sequencing (NGS) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Personalis Next-Generation Sequencing (NGS) Services Product Portfolio Table 90. Personalis Recent Development Table 91. Novogene Company Information Table 92. Novogene Business Overview Table 93. Novogene Next-Generation Sequencing (NGS) Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Novogene Next-Generation Sequencing (NGS) Services Product Portfolio Table 95. Novogene Recent Development Table 96. Genotypic Technology Company Information Table 97. Genotypic Technology Business Overview Table 98. Genotypic Technology Next-Generation Sequencing (NGS) Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Genotypic Technology Next-Generation Sequencing (NGS) Services Product Portfolio Table 100. Genotypic Technology Recent Development Table 101. Dna Link Company Information Table 102. Dna Link Business Overview Table 103. Dna Link Next-Generation Sequencing (NGS) Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Dna Link Next-Generation Sequencing (NGS) Services Product Portfolio Table 105. Dna Link Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Next-Generation Sequencing (NGS) Services Product Image Figure 2. Global Next-Generation Sequencing (NGS) Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next-Generation Sequencing (NGS) Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Next-Generation Sequencing (NGS) Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Targeted Sequencing Image Figure 8. Whole Exome Sequencing Image Figure 9. Whole Genome Sequencing Image Figure 10. Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Next-Generation Sequencing (NGS) Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Type (2021-2032) Figure 13. Hospitals and Clinics Image Figure 14. Biopharma Companies Image Figure 15. Academic & Research Organizations Image Figure 16. Others Image Figure 17. Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Next-Generation Sequencing (NGS) Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Application (2021-2032) Figure 20. Global Next-Generation Sequencing (NGS) Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Next-Generation Sequencing (NGS) Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Next-Generation Sequencing (NGS) Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Next-Generation Sequencing (NGS) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Next-Generation Sequencing (NGS) Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Next-Generation Sequencing (NGS) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Next-Generation Sequencing (NGS) Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Next-Generation Sequencing (NGS) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Next-Generation Sequencing (NGS) Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Next-Generation Sequencing (NGS) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Applications
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
Companies covered
  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Brooks Life Sciences
  • Macrogen
  • Personalis
  • Novogene
  • Genotypic Technology
  • Dna Link

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Next-Generation Sequencing (NGS) Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Next-Generation Sequencing (NGS) Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Next-Generation Sequencing (NGS) Services Market Dynamics
  1. 2.1 Next-Generation Sequencing (NGS) Services Industry Trends
  2. 2.2 Next-Generation Sequencing (NGS) Services Industry Drivers
  3. 2.3 Next-Generation Sequencing (NGS) Services Industry Opportunities and Challenges
  4. 2.4 Next-Generation Sequencing (NGS) Services Industry Restraints
3 Next-Generation Sequencing (NGS) Services Market by Company
  1. 3.1 Global Next-Generation Sequencing (NGS) Services Company Revenue Ranking in 2025
  2. 3.2 Global Next-Generation Sequencing (NGS) Services Revenue by Company (2021-2026)
  3. 3.3 Global Next-Generation Sequencing (NGS) Services Company Ranking (2024-2026)
  4. 3.4 Global Next-Generation Sequencing (NGS) Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Next-Generation Sequencing (NGS) Services Company Product Type and Application
  6. 3.6 Global Next-Generation Sequencing (NGS) Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Next-Generation Sequencing (NGS) Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Next-Generation Sequencing (NGS) Services Market by Type
  1. 4.1 Next-Generation Sequencing (NGS) Services Type Introduction
  2. 4.1.1 Targeted Sequencing
  3. 4.1.2 Whole Exome Sequencing
  4. 4.1.3 Whole Genome Sequencing
  5. 4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type
  6. 4.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value Share by Type (2021-2032)
5 Next-Generation Sequencing (NGS) Services Market by Application
  1. 5.1 Next-Generation Sequencing (NGS) Services Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Biopharma Companies
  4. 5.1.3 Academic & Research Organizations
  5. 5.1.4 Others
  6. 5.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application
  7. 5.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value Share by Application (2021-2032)
6 Next-Generation Sequencing (NGS) Services Regional Value Analysis
  1. 6.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Next-Generation Sequencing (NGS) Services Sales Value (2021-2032)
  7. 6.3.2 North America Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Next-Generation Sequencing (NGS) Services Sales Value (2021-2032)
  10. 6.4.2 Europe Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Next-Generation Sequencing (NGS) Services Sales Value (2021-2032)
  16. 6.6.2 South America Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2025 VS 2032
7 Next-Generation Sequencing (NGS) Services Country-level Value Analysis
  1. 7.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 Natera
  8. 8.2.1 Natera Company Information
  9. 8.2.2 Natera Business Overview
  10. 8.2.3 Natera Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Natera Next-Generation Sequencing (NGS) Services Product Portfolio
  12. 8.2.5 Natera Recent Developments
  13. 8.3 BGI
  14. 8.3.1 BGI Company Information
  15. 8.3.2 BGI Business Overview
  16. 8.3.3 BGI Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BGI Next-Generation Sequencing (NGS) Services Product Portfolio
  18. 8.3.5 BGI Recent Developments
  19. 8.4 Illumina
  20. 8.4.1 Illumina Company Information
  21. 8.4.2 Illumina Business Overview
  22. 8.4.3 Illumina Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Illumina Next-Generation Sequencing (NGS) Services Product Portfolio
  24. 8.4.5 Illumina Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Next-Generation Sequencing (NGS) Services Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 LabCorp
  32. 8.6.1 LabCorp Company Information
  33. 8.6.2 LabCorp Business Overview
  34. 8.6.3 LabCorp Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LabCorp Next-Generation Sequencing (NGS) Services Product Portfolio
  36. 8.6.5 LabCorp Recent Developments
  37. 8.7 Berry Genomics
  38. 8.7.1 Berry Genomics Company Information
  39. 8.7.2 Berry Genomics Business Overview
  40. 8.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Product Portfolio
  42. 8.7.5 Berry Genomics Recent Developments
  43. 8.8 Brooks Life Sciences
  44. 8.8.1 Brooks Life Sciences Company Information
  45. 8.8.2 Brooks Life Sciences Business Overview
  46. 8.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product Portfolio
  48. 8.8.5 Brooks Life Sciences Recent Developments
  49. 8.9 Macrogen
  50. 8.9.1 Macrogen Company Information
  51. 8.9.2 Macrogen Business Overview
  52. 8.9.3 Macrogen Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Macrogen Next-Generation Sequencing (NGS) Services Product Portfolio
  54. 8.9.5 Macrogen Recent Developments
  55. 8.10 Personalis
  56. 8.10.1 Personalis Company Information
  57. 8.10.2 Personalis Business Overview
  58. 8.10.3 Personalis Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Personalis Next-Generation Sequencing (NGS) Services Product Portfolio
  60. 8.10.5 Personalis Recent Developments
  61. 8.11 Novogene
  62. 8.11.1 Novogene Company Information
  63. 8.11.2 Novogene Business Overview
  64. 8.11.3 Novogene Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novogene Next-Generation Sequencing (NGS) Services Product Portfolio
  66. 8.11.5 Novogene Recent Developments
  67. 8.12 Genotypic Technology
  68. 8.12.1 Genotypic Technology Company Information
  69. 8.12.2 Genotypic Technology Business Overview
  70. 8.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Product Portfolio
  72. 8.12.5 Genotypic Technology Recent Developments
  73. 8.13 Dna Link
  74. 8.13.1 Dna Link Company Information
  75. 8.13.2 Dna Link Business Overview
  76. 8.13.3 Dna Link Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dna Link Next-Generation Sequencing (NGS) Services Product Portfolio
  78. 8.13.5 Dna Link Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst